Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Vet Parasitol ; 145(3-4): 287-96, 2007 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-17275191

RESUMEN

Fatty acid binding proteins (FABP) have been designed as a potential vaccine against fasciolosis. In this work, the immunoprophylaxis of the recombinant Fh15 FABP from F. hepatica (Fh15) in adjuvant/immunomodulator ADAD system was evaluated using mice and sheep challenged with F. hepatica. The ADAD system combines the Fh15 antigen with an immunomodulator (hydroalcoholic extract of Polypodium leucotomos; PAL) and/or an adjuvant (saponins of Quillaja saponaria; Qs) in a water/oil emulsion (30/70) with a non-mineral oil (Montanide). All the infected control mice died by 41-48 days post-infection. The mice vaccinated with ADAD only with PAL+Fh15 present a survival rate of 40-50% and those vaccinated with ADAD containing PAL+Qs+Fh15 had a survival rate of 50-62.5%. IgG1 antibodies were lower in surviving mice in comparison with non-surviving mice. The sheep vaccinated with ADAD PAL+Qs+Fh15 showed lower fluke recovery (43%), less hepatic lesions and higher post-infection daily weight gain than F. hepatica infected control animals. Thus, the ADAD system using recombinant fatty acid binding proteins from F. hepatica could be a good option to develop vaccines against F. hepatica.


Asunto(s)
Fascioliasis/prevención & control , Proteínas de Unión a Ácidos Grasos/inmunología , Proteínas Recombinantes/inmunología , Enfermedades de las Ovejas/prevención & control , Vacunas/inmunología , Animales , Química Farmacéutica , Fasciola hepatica/inmunología , Femenino , Ratones , Ratones Endogámicos BALB C , Ovinos , Enfermedades de las Ovejas/parasitología , Factores de Tiempo , Vacunas/administración & dosificación , Vacunas/química
2.
J Ethnopharmacol ; 71(1-2): 101-7, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10904152

RESUMEN

From the beginning of this decade and with the revival of the phytotherapy, biological research about immunomodulatory, anti-inflammatory and antiprotozoal effects of Central and South American plants have been in progress. Our objective was to determine the antiprotozoal activity of 79 extracts from different plant families, including Asteraceae, Araceae, Moraceae, Solanaceae, Rhamnaceae, Zingiberaceae, Leguminosae and Sapotaceae. Once matching with herbarium specimens authenticated the plants, selected parts were separated, dried carefully and reduced to powder. Most of the screened extracts were aqueous. Two protozoa with different metabolic pathways, Trypanosoma cruzi and Trichomonas vaginalis were used as experimental models. Trypanocidal activity of plants was assayed on epimastigote cultures in liver infusion tryptose (LIT). Anti-Trichomonas activity was determined over cultures of the parasite in Diamond medium. In both cases, microscopic counting of parasites, after their incubation in the presence of different concentrations of the crude extracts, were made in order to determine the cytocidal and cytostatic activities respect to control cultures. Of the nine extracts that showed antiprotozoal activity, those from Mikania cordifolia and Philodendron bipinnatifidum were then fractionated, and again, were assayed the organic and aqueous phases obtained.


Asunto(s)
Antiprotozoarios/farmacología , Extractos Vegetales/farmacología , Trichomonas vaginalis/efectos de los fármacos , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Américas , Animales , Evaluación Preclínica de Medicamentos , Trichomonas vaginalis/crecimiento & desarrollo , Trypanosoma cruzi/crecimiento & desarrollo
3.
Arzneimittelforschung ; 49(9): 764-9, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10514905

RESUMEN

In a search for antiprotozoan compounds, 34 new 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives were synthesized and tested in vitro against Trypanosoma cruzi and Trichomonas vaginalis. Some of them showed important antiprotozoan activity. In vivo assays of compounds which showed remarkable in vitro activity against T. vaginalis were carried out.


Asunto(s)
Antiprotozoarios/síntesis química , Tiadiazinas/síntesis química , Animales , Antiprotozoarios/farmacología , Antiprotozoarios/toxicidad , Antitricomonas/síntesis química , Antitricomonas/farmacología , Línea Celular , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Ratones , Tiadiazinas/farmacología , Tiadiazinas/toxicidad , Vaginitis por Trichomonas/tratamiento farmacológico , Vaginitis por Trichomonas/parasitología , Trichomonas vaginalis/efectos de los fármacos , Trypanosoma cruzi/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA